An Introduction to Dermato-oncology
Dermato-oncology is a rapidly evolving branch of dermatology focusing on the management, prevention and treatment of both prevalent and uncommon types of malignant skin tumours. These encompass a wide spectrum of skin tumours, from melanoma and epithelial skin cancers to tumours arising from neuroendocrine and lymphoid origins. The rise in the incidence of melanoma and other skin cancers has been propelled by population ageing. The integration of advanced diagnostic tools such as dermatoscopy and innovative therapies for advanced melanoma and nonmelanoma skin cancers has led to remarkable transformations in the structure of patient management within clinical environments.
Analysis of global non-melanoma skin cancer incidence and mortality: Thierry Passeron, EADV 2023
Non-melanoma skin cancer (NMSC) is responsible for a higher worldwide mortality rate compared to melanoma, a more severe type of skin cancer. A comprehensive analysis of global skin cancer incidence and mortality assessed global skin cancer epidemiology, emphasizing incidence, mortality, risk profiles, and dermatologist density’s impact. touchDERMATOLOGY caught up with Prof. Thierry Passeron (University Hospital […]
Brentuximab vedotin for the treatment of cutaneous T-cell lymphomas – real-world efficacy and safety findings: Adam Reich, EADV 2023
Brentuximab vedotin, an antibody–drug conjugate, was approved for the treatment of cutaneous T-cell lymphoma (CTCL) in Europe in 2017. In this touchDERMATOLOGY interview, we spoke with Prof. Adam Reich (University of Medicine, Wroclaw, Poland) to discuss the rationale and findings from his observational open-label study of brentuximab vedotin for CTCLs, assessing the real-world efficacy and […]
Optimizing the patient journey in CSCC through multidisciplinary collaboration
In this activity, leading experts discuss optimal approaches for the management of patients with CSCC and consider how effective multidisciplinary collaboration can contribute to improved outcomes.
- Define multidisciplinary best practices for diagnostic workup of cutaneous squamous cell carcinoma (CSCC) and identification of risk factors influencing prognosis
- Outline interdisciplinary eligibility criteria for surgery and radiotherapy in patients with CSCC
- Determine the optimal use of systemic therapies in patients with unresectable locally advanced or metastatic CSCC and the role of the multidisciplinary tumour board in sharing clinical decisions in cancer care
Navigating the emerging complexities of melanoma treatment: New insights for clinical practice
Watch leading experts discuss evolving neoadjuvant, adjuvant and metastatic treatment options for patients with melanoma, taking in the latest data presented at the ESMO Congress 2021.
- Describe the long-term survival results in patients with melanoma and their relevance to treatment decisions
- Evaluate current strategies to improve outcomes for patients with melanoma who do not experience a durable response
- Recall the latest data for emerging treatment options, including the use of triple combination approaches, and how these therapies fit into the melanoma treatment paradigm
Immunotherapy and evolving approaches for basal cell carcinoma
Watch leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care.
- Recognize the current unmet needs and rationale for alternative treatment options for patients with basal cell carcinoma (BCC)
- Evaluate the latest data for using immunotherapy to treat patients with advanced BCC
- Define how the latest advances in BCC may impact clinical practice